Clorox (NYSE:CLX) Given New $128.00 Price Target at Deutsche Bank Aktiengesellschaft

Clorox (NYSE:CLX) had its price objective trimmed by Deutsche Bank Aktiengesellschaft from $135.00 to $128.00 in a research report sent to investors on Monday,MarketScreener reports. The firm currently has a hold rating on the stock.

Several other analysts have also issued reports on CLX. Barclays dropped their price objective on Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a research note on Tuesday, September 30th. Bank of America dropped their price objective on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. Wells Fargo & Company dropped their price objective on Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Thursday, September 25th. The Goldman Sachs Group dropped their price objective on Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research note on Wednesday, October 1st. Finally, Morgan Stanley decreased their target price on Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a research report on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, Clorox has an average rating of “Reduce” and a consensus target price of $131.64.

Clorox Stock Performance

CLX opened at $120.51 on Monday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The business’s 50-day simple moving average is $122.14 and its 200 day simple moving average is $128.40. The firm has a market capitalization of $14.67 billion, a PE ratio of 18.48, a PEG ratio of 0.98 and a beta of 0.52. Clorox has a 52-week low of $116.53 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, sell-side analysts expect that Clorox will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. Clorox’s dividend payout ratio is currently 76.07%.

Insider Transactions at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.63% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Clorox

Large investors have recently added to or reduced their stakes in the stock. Simplicity Wealth LLC grew its position in Clorox by 157.3% during the second quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock worth $2,199,000 after buying an additional 11,198 shares in the last quarter. Raymond James Financial Inc. grew its position in Clorox by 15.6% during the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after buying an additional 36,352 shares in the last quarter. OneDigital Investment Advisors LLC acquired a new stake in Clorox during the first quarter worth approximately $247,000. Brown Miller Wealth Management LLC acquired a new stake in Clorox during the first quarter worth approximately $399,000. Finally, Roman Butler Fullerton & Co. bought a new stake in Clorox during the first quarter worth $400,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.